Healthcare -
Biotechnology - NASDAQ - FR
$ 1.69
1.2 %
$ 142 M
Market Cap
-3.93
P/E
IPHA - OPERATING INCOME
Operating Income IPHA - Innate Pharma S.A.
-12.7 M
LAST VALUE
48.53%
2 YEAR CAGR
-28.19%
5 YEAR CAGR
-16.32%
10 YEAR CAGR